darbepoetin alfa

CHEBI:CHEBI_748821

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

pharm_class_epc
Erythropoiesis-stimulating Agent [EPC]
pharm_class
Increased Erythroid Cell Production [PE]
pharm_class_cs
Erythropoietin [CS]
pharm_class_pe
Increased Erythroid Cell Production [PE]
upc
0355513006019
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
generic_name
darbepoetin alfa
rxcui
1654955
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
marketing_category
BLA
active_ingredient_strength
60 ug/.3mL
marketing_start_date
20060607
package_marketing_start_date
20060607
brand_name
ARANESP
brand_name_base
ARANESP
product_ndc
55513-003
application_number
BLA103951
labeler_name
Amgen Inc
manufacturer_name
Amgen Inc
spl_id
d4b13c08-a06e-4706-846c-7562385f170c
active_ingredient_name
DARBEPOETIN ALFA
package_ndc
55513-003-04
package_description
4 VIAL, SINGLE-DOSE in 1 PACKAGE (55513-003-04) / 1 mL in 1 VIAL, SINGLE-DOSE (55513-003-01)
unii
15UQ94PT4P
spl_set_id
0fd36cb9-c4f6-4167-93c9-8530865db3f9
nui
N0000009319